Published on in CHOP News
For patients fighting sickle cell disease, finding compassionate care is part of the battle. A CHOP hematologist discusses the importance of caring for patients beyond the hospital.
Published on in CHOP News
Study finds two laboratory findings can distinguish the autoimmune pathogenesis of aplastic anemia from other inherited bone marrow disorders.
Published on in CHOP News
A collaborative team of researchers, including Dr. Stephan Grupp, recently presented preliminary data showing that a CRISPR-based gene-editing therapy for inherited blood disorders is safe and effective.
Published on in CHOP News
Kwaku Ohene-Frempong, MD was named a 2021 Honorific Award Recipient by the American Society of Hematology.
Published on in CHOP News
CHOP researchers have developed a proof-of-concept treatment for blood disorders like sickle cell disease that elevates both fetal and adult hemoglobin.
Published on in CHOP News
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
Published on in CHOP News
CHOP researchers have identified BAFF as a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A.
Published on in CHOP News
The findings identify possible targets for future therapies for ribosomopathies, childhood disorders that lead to bone marrow failure (BMF).
Published on in CHOP News
CHOP researchers have developed a gene therapy vector for sickle cell disease and other blood disorder that is potentially superior to competitors.
Published on in CHOP News
CHOP researchers identified an in vivo role for activated protein C (APC), which could potentially be exploited for future hemophilia A treatments.